Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |